· Published by Health Canada · Official notice
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
U.K. Medicines and Healthcare products Regulatory Agency (MHRA)
Therma Power and Grenade Fat Burner are promoted for weight loss.
Therma Power comes in two varieties: Therma Power "red," which contains Ephedra, and Therma Power "blue," which is Ephedra-free.
Grenade Fat Burner is sold in 100-tablet containers.
The MHRA warned consumers not to use the ephedrine-containing products Therma Power (red variety) and Grenade Fat Burner after the products were associated with serious adverse reactions, including a report of death.
The MHRA also warned consumers about the ephedrine-free (blue) variety of Therma Power, because it contains synephrine and caffeine, a combination that has been associated with cardiovascular adverse reactions.
Use of products containing Ephedra or ephedrine in combination with caffeine and other stimulants may cause serious, possibly fatal, adverse effects. Health Canada has previously warned consumers against the use of unauthorized Ephedra/ephedrine-containing products, in 2005, 2006 and 2008, due to the risk of serious adverse effects.
Synephrine is a substance similar to ephedrine and may have similar cardiovascular adverse effects that could lead to stroke, heart attack and/or death. Caffeine is a stimulant that can significantly increase the effects of synephrine.
Ephedra is a plant source of the active ingredient ephedrine. Side effects associated with the use of ephedrine include dizziness, headache, decreased appetite, anxiety, restlessness or nervousness, digestive problems, irregular or fast heartbeat, insomnia, flushing, sweating, high blood pressure, stroke, seizures, psychosis and death:
Use of products containing Ephedra/ephedrine or synephrine is not recommended for people with heart problems, high blood pressure, thyroid disease, diabetes, enlarged prostate, anxiety and restlessness, glaucoma (serious eye disorder) and pheochromocytoma (serious gland disorder).
Consumers should use Ephedra/ephedrine products only for nasal decongestion, and should not exceed the maximum allowable dosage described in the Ephedra and ephedrine labelling standards, unless recommended and supervised by a health care practitioner. Labelling standards for Ephedra and ephedrine are on the Health Canada web site. These products should be avoided during pregnancy and lactation.
Weight-loss products containing synephrine are not authorized for sale in Canada.
Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.
Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.